Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies […]
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5 […]
This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry. […]
The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]
Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing. […]
September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new Advanced Practice Clinical Laboratory Training Center opened its doors this week and took a bold step toward solving a nationwide shortage of clinical laboratory scientists. This state-of-the-art facility is more than a training site; it’s a model […]
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy […]
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) […]
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study […]
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy […]
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP […]
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes […]